Page last updated: 2024-10-27

fluoxetine and Mitochondrial Diseases

fluoxetine has been researched along with Mitochondrial Diseases in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wen, L1
Jin, Y1
Li, L1
Sun, S1
Cheng, S1
Zhang, S1
Zhang, Y1
Svenningsson, P1

Other Studies

1 other study available for fluoxetine and Mitochondrial Diseases

ArticleYear
Exercise prevents raphe nucleus mitochondrial overactivity in a rat depression model.
    Physiology & behavior, 2014, Jun-10, Volume: 132

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Bra

2014